Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02693483
Other study ID # povidone iodine
Secondary ID
Status Recruiting
Phase Phase 4
First received February 15, 2016
Last updated February 25, 2016
Start date April 2015
Est. completion date October 2016

Study information

Verified date February 2016
Source Ain Shams Maternity Hospital
Contact Amr A Riad, MD
Phone 01005347179
Email amr.riad@med.asu.edu.eg
Is FDA regulated No
Health authority Egypt: Ministry of Health and Population
Study type Interventional

Clinical Trial Summary

Preoperative vaginal cleansing with povidone iodine and the risk of post cesarean endometritis.


Description:

Study Population:

Women undergoing cesarean sections will be enrolled in this study after obtaining verbal consent as there are no extra interventional measures that will be undertaken in the study apart from routine investigations and procedures done during cesarean sections, being already approved in signed consent to undergo treatment.

The nature and aim of the work will be fully discussed to all women who will agree to participate in the study. Verbal consent will be obtained from all patients enrolled in the study which is approved by the local ethical committee.

Preoperative evaluation of patients included:

1. Medical history taking including:

- Personal (name, age)

- Complaint (in patient word)

- Present history

- Medical history (Diabetes mellitus, Hypertension)

- Past history (any surgeries)

- Family history

2. Physical examination including vital data (blood pressure,pulse, temperature)

3. Routine hematologic laboratory tests including complete blood picture & random blood sugar.

4. The surgical site will be assessed at least once before cesarean section if the participant presented to emergency department with findings concerning for surgical-site infection.

5. Indication for cesarean section.

6. Duration of ruptured membranes if found.

7. Risk of infection including Diabetes mellitus, immuno-compromised, rupture of membranes and corticosteroid therapy.

Steps:

Patients In the study group (povidone iodine group) patients will be prepared with vaginal cleansing with povidone-iodine along with the usual abdominal scrub. Vaginal cleansing will be done with 3 gauze pieces soaked with 10% povidone iodine in a sterilized bowl and the scrub will be done from the vaginal apex to introitus with attention to the anterior, posterior and lateral vaginal wall. After vaginal cleansing the gloves will be changed to perform the abdominal scrub.

Patients in the control group (no vaginal cleansing group) will not have any vaginal wash (even tap water will not be used).

In both groups, patients will receive preoperative per protocol prophylactic I.V. antibiotics (third generation cephalosporin ) before skin incision.

Operative technique:

During this study all cases will be subjected to exclusion and inclusion criteria. Any risk of infection will be assessed including rupture of membranes, Diabetes mellitus, immune-compromised and corticosteroid therapy….etc. Cesarean section will be performed with estimation of operative duration in time and mean operative blood loss.

Post operative care:

Follow up for temperature of 38°C and greater during first 24 hours of surgery and endometritis will be diagnosed by fever 38.4°C and greater with any of the following (uterine tenderness ,foul smelling lochia or positive C-reactive protein).

Mean hospital stay in days will be determined. N.B: Culture of the upper genital tract are virtually impossible to obtain without contaminating the specimen by the microorganisms in the vagina. Therefore, they rarely add significant information that enhances clinical decision-making.


Recruitment information / eligibility

Status Recruiting
Enrollment 306
Est. completion date October 2016
Est. primary completion date June 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

1. Patients 18-40 years of age who will undergo cesarean deliveries.

2. Able to communicate well with the investigator & to comply with the requirements of the entire study.

3. Verbal consent obtained from subject and husband / witness before undergoing the study entry (with the understanding that consent may be withdrawn by the patient at any time without prejudice).

Exclusion Criteria:

1. Patients with allergy to iodine containing solutions.

2. Patients with ante-partum hemorrhage.

3. Patients with ruptured membranes.

4. Patients with any known disease that increases the risk of infection e.g. immunocompromized, those receiving steroids ...etc.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Drug:
10% povidone iodine
Vaginal cleansing will be done with 3 gauze pieces soaked with 10% povidone iodine in a sterilized bowl and the scrub will be done from the vaginal apex to introitus with attention to the anterior, posterior and lateral vaginal wall

Locations

Country Name City State
Egypt Ain Shams maternity hospital Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams Maternity Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Subjects with post cesarean endometritis Number of Subjects with post cesarean endometritis as diagnosed by fever 38.4°C and greater in first 48 hours after cesarean section with any of the following (uterine tenderness, foul smelling lochia or positive C-reactive protein) 48 hours Yes
Secondary Number of Subjects with allergic reaction to povidone iodine Number of Subjects with allergic reaction to povidone iodine 48 hours Yes
See also
  Status Clinical Trial Phase
Recruiting NCT02685761 - Skin Incisions and Wound Complication Rates for C-sections in Obese Women N/A
Completed NCT02865993 - Betadine Irrigation in Cesarean Section N/A
Completed NCT01890720 - Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section N/A
Completed NCT01891006 - Intervention for Postpartum Infections Following Caesarean Section N/A
Completed NCT02168023 - Study to Evaluate DACC Dressings for the Prevention of Surgical Site Infections in Women Undergoing Caesarean Section. N/A
Completed NCT02072798 - Antibiotics and Gut Microbiota Among Newborn Infants Phase 4
Completed NCT00603603 - Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity N/A
Completed NCT02049944 - Increased Cefazolin During Cesarean Delivery in Obese Population Phase 4
Completed NCT02402907 - STRIPES Study: Study To Reduce Infection Post cEsarean Section N/A